We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
18 hedge funds and large institutions have $798K invested in Atossa Therapeutics in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
13% more funds holding
Funds holding: 16 → 18 (+2)
0.24% more ownership
Funds ownership: 0.69% → 0.92% (+0.24%)
19% less capital invested
Capital invested by funds: $991K → $798K (-$193K)
Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$73.9K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$49.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$45.4K |
| 5 |
Barclays
London,
United Kingdom
|
+$42.7K |
Top Sellers
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3.13K |
| 2 |
Jane Street
New York
|
-$1.66K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
-$1K |